Leonardo Silva de Sousa, Alexandre Lopes Andrade, Aryane de Azevedo Pinheiro, Felipe Diógenes Abreu, Eduardo Henrique Silva Sousa, Idalina Maria Moreira de Carvalho, Débora S C M Castelo-Branco, Mayron Alves de Vasconcelos, Edson Holanda Teixeira
{"title":"Antibacterial and antibiofilm activity of ruthenium polypyridine complex against <i>Staphylococcus</i> strains.","authors":"Leonardo Silva de Sousa, Alexandre Lopes Andrade, Aryane de Azevedo Pinheiro, Felipe Diógenes Abreu, Eduardo Henrique Silva Sousa, Idalina Maria Moreira de Carvalho, Débora S C M Castelo-Branco, Mayron Alves de Vasconcelos, Edson Holanda Teixeira","doi":"10.1080/08927014.2025.2558627","DOIUrl":null,"url":null,"abstract":"<p><p>This study reports the synthesis of a new polypyridine ruthenium(II) complex, [Ru(anth)<sub>3</sub>]<sup>2+</sup>, which generates singlet oxygen (Φ<sub>Δ</sub> = 0.98) and binds DNA (K<sub>b</sub> = 9.8 × 10<sup>4</sup> M<sup>-1</sup>), leading to bacterial damage. The compound exhibited minimum inhibitory concentrations (MICs) of 31.25 µg mL<sup>-1</sup> against <i>S. aureus</i> ATCC 700698 and <i>S. epidermidis</i> ATCC 35984, and 125 µg mL<sup>-1</sup> against <i>S. aureus</i> ATCC 25923 and <i>S. epidermidis</i> ATCC 12228. The compound showed synergistic effects with ampicillin and additive effects with tetracycline. The complex significantly reduced biofilm biomass, viable cell counts, and metabolic activity. Scanning electron and confocal laser microscopy confirmed surface disruption and reduced viability. Gel electrophoresis indicated light-induced DNA photocleavage. Cytotoxicity in L929 fibroblasts was observed only above 125 µg mL<sup>-1</sup>. These findings suggest that [Ru(anth)<sub>3</sub>]<sup>2+</sup> is a promising antimicrobial agent with multi-target activity, supporting its potential for antimicrobial drug development.</p>","PeriodicalId":8898,"journal":{"name":"Biofouling","volume":" ","pages":"1-17"},"PeriodicalIF":2.0000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biofouling","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/08927014.2025.2558627","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This study reports the synthesis of a new polypyridine ruthenium(II) complex, [Ru(anth)3]2+, which generates singlet oxygen (ΦΔ = 0.98) and binds DNA (Kb = 9.8 × 104 M-1), leading to bacterial damage. The compound exhibited minimum inhibitory concentrations (MICs) of 31.25 µg mL-1 against S. aureus ATCC 700698 and S. epidermidis ATCC 35984, and 125 µg mL-1 against S. aureus ATCC 25923 and S. epidermidis ATCC 12228. The compound showed synergistic effects with ampicillin and additive effects with tetracycline. The complex significantly reduced biofilm biomass, viable cell counts, and metabolic activity. Scanning electron and confocal laser microscopy confirmed surface disruption and reduced viability. Gel electrophoresis indicated light-induced DNA photocleavage. Cytotoxicity in L929 fibroblasts was observed only above 125 µg mL-1. These findings suggest that [Ru(anth)3]2+ is a promising antimicrobial agent with multi-target activity, supporting its potential for antimicrobial drug development.
期刊介绍:
Biofouling is an international, peer-reviewed, multi-discliplinary journal which publishes original articles and mini-reviews and provides a forum for publication of pure and applied work on protein, microbial, fungal, plant and animal fouling and its control, as well as studies of all kinds on biofilms and bioadhesion.
Papers may be based on studies relating to characterisation, attachment, growth and control on any natural (living) or man-made surface in the freshwater, marine or aerial environments, including fouling, biofilms and bioadhesion in the medical, dental, and industrial context.
Specific areas of interest include antifouling technologies and coatings including transmission of invasive species, antimicrobial agents, biological interfaces, biomaterials, microbiologically influenced corrosion, membrane biofouling, food industry biofilms, biofilm based diseases and indwelling biomedical devices as substrata for fouling and biofilm growth, including papers based on clinically-relevant work using models that mimic the realistic environment in which they are intended to be used.